Photodynamic therapy responsiveness using mono-1-aspartyl chlorin e6 (Invited Paper)

Angela Ferrario; Charles J. Gomer

doi:10.1117/12.60931

1 June 1992 Photodynamic therapy responsiveness using mono-1-aspartyl chlorin e₆ (Invited Paper)

Angela Ferrario, Charles J. Gomer

Proceedings Volume 1645, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy; (1992) https://doi.org/10.1117/12.60931
Event: OE/LASE '92, 1992, Los Angeles, CA, United States

Abstract

The porphyrin derivative Photofrin-Il (PH-Il) is associated with positive photodynarnic therapy (PDT) responses (1,5) . However several properties of this photosensitizer, such as minimal absorption above 600 nm, chemical impurity and prolonged in-vivo retention, are not optimal. New photosensitizers are being synthesized and evaluated in an attempt to improve the efficacy of PDT (6) . Compounds with increased absorption further in the near infrared will improve photon utilization and depth of light penetration within tissue (7) . Derivatives of porphyrins, chlorins and phthalocyanines are among the compounds being examined (8, 9) . One second generation compound, mono-l--aspartyl chiorin e6 (NPe6), is an hydrophilic chlorin which exhibits promising in-vitro and in-vivo photosensitizing properties (8, 10-14) . N2e6 is chemically pure and has significant absorption at 664 nm. The photosensitizer appears to localize in the lysosomal compartment in cells and has in-vivo tissue distribution properties similar to PH-Il (12,14) . NPe6 mediated PDT is effective against a mouse mammary carcinoma when short time intervals (4-6 hours) between drug injection and light exposure are used (8) . Clearance of N2e6 from blood accounts for the minimal tumor and skin photosensitivity when a 24 hr interval between drug administration and light treatment is used. In the current study, we evaluated in-vivo metabolic properties of NPe6 and quantified PDT responsiveness as a function of the time interval between drug administration and light treatment.

Citation Download Citation

Angela Ferrario and Charles J. Gomer "Photodynamic therapy responsiveness using mono-1-aspartyl chlorin e₆ (Invited Paper)", Proc. SPIE 1645, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy, (1 June 1992); https://doi.org/10.1117/12.60931

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available